Example of Current Pharmaceutical Design format
Recent searches

Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format Example of Current Pharmaceutical Design format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Current Pharmaceutical Design — Template for authors

Publisher: Bentham Science
Categories Rank Trend in last 3 yrs
Pharmacology #96 of 297 down down by 21 ranks
Drug Discovery #48 of 145 down down by 17 ranks
journal-quality-icon Journal quality:
Good
calendar-icon Last 4 years overview: 1955 Published Papers | 10470 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 13/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

Taylor and Francis

Quality:  
High
CiteRatio: 8.2
SJR: 1.864
SNIP: 1.641
open access Open Access
recommended Recommended

American Chemical Society

Quality:  
High
CiteRatio: 6.5
SJR: 0.976
SNIP: 1.593
open access Open Access

Dove Medical Press

Quality:  
High
CiteRatio: 5.6
SJR: 0.964
SNIP: 1.233
open access Open Access
recommended Recommended

Elsevier

Quality:  
High
CiteRatio: 9.3
SJR: 1.868
SNIP: 1.29

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

2.208

8% from 2018

Impact factor for Current Pharmaceutical Design from 2016 - 2019
Year Value
2019 2.208
2018 2.412
2017 2.757
2016 2.611
graph view Graph view
table view Table view

5.4

6% from 2019

CiteRatio for Current Pharmaceutical Design from 2016 - 2020
Year Value
2020 5.4
2019 5.1
2018 5.3
2017 5.8
2016 6.6
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has decreased by 8% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has increased by 6% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

0.69

14% from 2019

SJR for Current Pharmaceutical Design from 2016 - 2020
Year Value
2020 0.69
2019 0.606
2018 0.703
2017 0.883
2016 1.069
graph view Graph view
table view Table view

0.771

17% from 2019

SNIP for Current Pharmaceutical Design from 2016 - 2020
Year Value
2020 0.771
2019 0.659
2018 0.684
2017 0.749
2016 0.822
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has increased by 14% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 17% in last years.
  • This journal’s SNIP is in the top 10 percentile category.
Current Pharmaceutical Design

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Bentham Science

Current Pharmaceutical Design

Current Pharmaceutical Design publishes timely in-depth reviews from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged auth...... Read More

Pharmacology

Drug Discovery

Pharmacology, Toxicology and Pharmaceutics

i
Last updated on
13 Jul 2020
i
ISSN
1381-6128
i
Impact Factor
Medium - 0.973
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Yellow faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
Vancouver
i
Citation Type
Numbered
[25]
i
Bibliography Example
Blonder, G E, Tinkham, M, & Klapwijk, T M. Transition from metallic to tunnel- ing regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys. Rev. B. 2013;87(10):100510.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.2174/13816128113199990617
Internet addiction: a systematic review of epidemiological research for the last decade.
Daria J. Kuss, Mark D. Griffiths, Laurent Karila, Joël Billieux1

Abstract:

In the last decade, Internet usage has grown tremendously on a global scale. The increasing popularity and frequency of Internet use has led to an increasing number of reports highlighting the potential negative consequences of overuse. Over the last decade, research into Internet addiction has proliferated. This paper review... In the last decade, Internet usage has grown tremendously on a global scale. The increasing popularity and frequency of Internet use has led to an increasing number of reports highlighting the potential negative consequences of overuse. Over the last decade, research into Internet addiction has proliferated. This paper reviews the existing 68 epidemiological studies of Internet addiction that (i) contain quantitative empirical data, (ii) have been published after 2000, (iii) include an analysis relating to Internet addiction, (iv) include a minimum of 1000 participants, and (v) provide a full-text article published in English using the database Web of Science. Assessment tools and conceptualisations, prevalence, and associated factors in adolescents and adults are scrutinised. The results reveal the following. First, no gold standard of Internet addiction classification exists as 21 different assessment instruments have been identified. They adopt official criteria for substance use disorders or pathological gambling, no or few criteria relevant for an addiction diagnosis, time spent online, or resulting problems. Second, reported prevalence rates differ as a consequence of different assessment tools and cut-offs, ranging from 0.8% in Italy to 26.7% in Hong Kong. Third, Internet addiction is associated with a number of sociodemographic, Internet use, and psychosocial factors, as well as comorbid symptoms and disorder in adolescents and adults. The results indicate that a number of core symptoms (i.e., compulsive use, negative outcomes and salience) appear relevant for diagnosis, which assimilates Internet addiction and other addictive disorders and also differentiates them, implying a conceptualisation as syndrome with similar etiology and components, but different expressions of addictions. Limitations include the exclusion of studies with smaller sample sizes and studies focusing on specific online behaviours. Conclusively, there is a need for nosological precision so that ultimately those in need can be helped by translating the scientific evidence established in the context of Internet addiction into actual clinical practice. read more read less

Topics:

Addiction (58%)58% related to the paper, The Internet (57%)57% related to the paper
View PDF
974 Citations
Journal Article DOI: 10.2174/138161208784246207
Anti-cancer drugs

Topics:

Introductory Journal Article (52%)52% related to the paper
882 Citations
Journal Article DOI: 10.2174/138161205774913255
Uric acid and oxidative stress.
Glantzounis G1, Evangelos C. Tsimoyiannis, A. M. Kappas, Dimitrios Galaris

Abstract:

Uric acid is the final product of purine metabolism in humans. The final two reactions of its production catalyzing the conversion of hypoxanthine to xanthine and the latter to uric acid are catalysed by the enzyme xanthine oxidoreductase, which may attain two inter-convertible forms, namely xanthine dehydrogenase or xanthine... Uric acid is the final product of purine metabolism in humans. The final two reactions of its production catalyzing the conversion of hypoxanthine to xanthine and the latter to uric acid are catalysed by the enzyme xanthine oxidoreductase, which may attain two inter-convertible forms, namely xanthine dehydrogenase or xanthine oxidase. The latter uses molecular oxygen as electron acceptor and generates superoxide anion and other reactive oxygen products. The role of uric acid in conditions associated with oxidative stress is not entirely clear. Evidence mainly based on epidemiological studies suggests that increased serum levels of uric acid are a risk factor for cardiovascular disease where oxidative stress plays an important pathophysiological role. Also, allopurinol, a xanthine oxidoreductase inhibitor that lowers serum levels of uric acid exerts protective effects in situations associated with oxidative stress (e.g. ischaemia-reperfusion injury, cardiovascular disease). However, there is increasing experimental and clinical evidence showing that uric acid has an important role in vivo as an antioxidant. This review presents the current evidence regarding the antioxidant role of uric acid and suggests that it has an important role as an oxidative stress marker and a potential therapeutic role as an antioxidant. Further well designed clinical studies are needed to clarify the potential use of uric acid (or uric acid precursors) in diseases associated with oxidative stress. read more read less

Topics:

Xanthine oxidase (73%)73% related to the paper, Uric acid (67%)67% related to the paper, Allopurinol (62%)62% related to the paper, Xanthine (61%)61% related to the paper, Xanthine dehydrogenase (59%)59% related to the paper
827 Citations
Journal Article DOI: 10.2174/1381612043382710
Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities.

Abstract:

Several natural products with a coumarinic moiety have been reported to have multiple biological activities. It is to be expected that, in a similar way to isomeric flavonoids, coumarins might affect the formation and scavenging of reactive oxygen species (ROS) and influence processes involving free radical-mediated injury. C... Several natural products with a coumarinic moiety have been reported to have multiple biological activities. It is to be expected that, in a similar way to isomeric flavonoids, coumarins might affect the formation and scavenging of reactive oxygen species (ROS) and influence processes involving free radical-mediated injury. Coumarin can reduce tissue edema and inflammation. Moreover coumarin and its 7-hydroxy-derivative inhibit prostaglandin biosynthesis, which involves fatty acid hydroperoxy intermediates. Natural products like esculetin, fraxetin, daphnetin and other related coumarin derivatives are recognised as inhibitors not only of the lipoxygenase and cycloxygenase enzymic systems, but also of the neutrophil-dependent superoxide anion generation. Due to the unquestionable importance of coumarin derivatives considerable efforts have been made by several investigators, to prepare new compounds bearing single substituents, or more complicated systems, including heterocyclic rings mainly at 3-, 4- and / or 7-positions. In this review we shall deal with naturally occurring or synthetically derived coumarin derivatives, which possess antiinflammatory as well as antioxidant activities. read more read less

Topics:

Fraxetin (58%)58% related to the paper, Coumarin (51%)51% related to the paper
813 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Current Pharmaceutical Design.

It automatically formats your research paper to Bentham Science formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Current Pharmaceutical Design format uses Vancouver citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Current Pharmaceutical Design in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Current Pharmaceutical Design guidelines and auto format it.

2. Do you follow the Current Pharmaceutical Design guidelines?

Yes, the template is compliant with the Current Pharmaceutical Design guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Current Pharmaceutical Design?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Current Pharmaceutical Design citation style.

4. Can I use the Current Pharmaceutical Design templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Current Pharmaceutical Design.

5. Can I use a manuscript in Current Pharmaceutical Design that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Current Pharmaceutical Design that you can download at the end.

6. How long does it usually take you to format my papers in Current Pharmaceutical Design?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Current Pharmaceutical Design.

7. Where can I find the template for the Current Pharmaceutical Design?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Current Pharmaceutical Design's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Current Pharmaceutical Design's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Current Pharmaceutical Design an online tool or is there a desktop version?

SciSpace's Current Pharmaceutical Design is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Current Pharmaceutical Design?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Current Pharmaceutical Design?”

11. What is the output that I would get after using Current Pharmaceutical Design?

After writing your paper autoformatting in Current Pharmaceutical Design, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Current Pharmaceutical Design's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Current Pharmaceutical Design?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Current Pharmaceutical Design. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Current Pharmaceutical Design?

The 5 most common citation types in order of usage for Current Pharmaceutical Design are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Current Pharmaceutical Design?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Current Pharmaceutical Design's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Current Pharmaceutical Design in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Current Pharmaceutical Design Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Current Pharmaceutical Design formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template